Cannabis Stock Gainers And Losers From January 25, 2021

GAINERS:
- Primo Nutraceuticals (OTC:BUGVF) shares closed up 80% at $0.90
- MGC Pharmaceuticals (OTC:MGCLF) shares closed up 55% at $0.03
- High Tide (OTCQB:HITIF) shares closed up 21.77% at $0.47
- BioHarvest Sciences (OTC:CNVCF) shares closed up 17.33% at $0.47
- Helix Technologies (OTCQB:HLIX) shares closed up 10.94% at $0.71
- Cannabix Technologies (OTC:BLOZF) shares closed up 8.39% at $1.28
- CURE Pharmaceutical Hldg (OTCQB:CURR) shares closed up 6.06% at $1.40
- Cara Therapeutics (NASDAQ:CARA) shares closed up 2.61% at $19.65
LOSERS:
- iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 30.98% at $0.29
- ReneSola (NYSE:SOL) shares closed down 21.99% at $26.18
- General Cannabis (OTCQB:CANN) shares closed down 14.58% at $1.03
- Aleafia Health (OTCQX:ALEAF) shares closed down 10.34% at $0.60
- Origin Agritech (NASDAQ:SEED) shares closed down 9.67% at $19.15
- Green Organic Dutchman (OTCQX:TGODF) shares closed down 7.85% at $0.25
- The Flowr (OTC:FLWPF) shares closed down 7.75% at $0.29
- Aphria (NASDAQ:APHA) shares closed down 7.04% at $12.01
- Cronos Group (NASDAQ:CRON) shares closed down 6.95% at $9.91
- Charlottes Web Holdings (OTCQX:CWBHF) shares closed down 6.58% at $4.40
- EnWave (OTC:NWVCF) shares closed down 6.53% at $1.00
- cbdMd, Inc. (AMEX:YCBD) shares closed down 6.25% at $3.45
- Neptune Wellness Solns (NASDAQ:NEPT) shares closed down 6.09% at $1.85
- Aurora Cannabis (NYSE:ACB) shares closed down 4.74% at $10.16
- Tilray (NASDAQ:TLRY) shares closed down 4.63% at $17.19
- Cresco Labs (OTCQX:CRLBF) shares closed down 4.32% at $13.58
- Bloom Energy (NYSE:BE) shares closed down 4.16% at $38.50
- Green Thumb Industries (OTCQX:GTBIF) shares closed down 2.88% at $29.72
- Canopy Gwth (NASDAQ:CGC) shares closed down 2.63% at $32.91
- Encompass Health (NYSE:EHC) shares closed down 2.03% at $85.70
Check out a full list of cannabis stock movers in real time following this link.
Lead image by Ilona Szentivanyi. Copyright: Benzinga.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.